Clinical Trial Update: Expanding Coverage of Continuous Subcutaneous Insulin Infusion in Pediatric Patients With Diabetes [NA]

View source ↗

Summary

A pediatric trial evaluating expanded coverage for continuous subcutaneous insulin infusion in Type 1 diabetes has been withdrawn. The sponsor listed is Childre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Type 1 Diabetes | NA | Status: WITHDRAWN